Single Use Bioreactors Market Revenue to Cross USD 6 billion by 2035 | Roots Analysis

Published: August 2023


According to a recently published report by Roots Analysis, the rising demand for efficacious biotherapeutics and various benefits associated with single-use systems are driving the single use bioreactors market growth

Single Use Bioreactors Industry Overview

The global single use bioreactors market is anticipated to grow at a CAGR of 17% from 2023-2035, reaching USD 6 billion by 2035.

Over the years, adoption of single use bioreactors in the biopharmaceutical industry has been on the rise. The growing adoption of bioprocessing systems is mainly driven by various cost saving and other benefits, such as overall ease of use, high throughput, simple sterilization and contamination management.  Moreover, single-use systems have a low footprint, are easy to transport and made-up of the US FDA approved materials, such as ethylene-vinyl acetate, polycarbonate, polyethylene, and polystyrene. As a result, single-use systems are being preferred over conventional stainless steel bioreactors. In fact, single-use technologies are anticipated to be adopted by around 90% of the biopharmaceutical industry over the coming years.  Further, considering their smaller footprint and operational flexibility, several academic institutes have also started to adopt these technologies.

Browse 115+ figures and 160+ market data tables spread across 355+ pages and detailed Table of Content on “Single Use Bioreactors Market by Type of Bioreactor, Scale of Operation, Type of Cell Culture, Type of Biologics Synthesized, Application Area, End-users, and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035” here: https://www.rootsanalysis.com/reports/single-use-bioreactors-market.html

Market Drivers

Over the years, several factors have been responsible for driving the market growth of single use bioreactors. These factors include rapid biomanufacturing, reduced risk of cross contamination and cost efficiency. Owing to the disposable nature of equipment use with these bioreactors, they significantly reduce the operational cost and also reduces the capital investment, when compared with the conventional bioreactors. Moreover, the single use bioreactors offer high product flexibility, quicker turnaround and lesser batch-to-batch inconsistencies. Considering the afore-mentioned benefits, the demand for single use bioreactors is anticipated to grow significantly, thereby driving the single use bioreactors market growth.

Market Restraints

The players existing in this domain have realized various parameters that have limited the market growth of single use bioreactors. Examples of these restraints associated with this industry include limited volume production, stringent regulatory compliance guidelines and various environmental concerns. Due to the evolving guidelines of regulatory bodies across the world, ensuring regulatory compliance has become challenging. Moreover, single use bioreactors are associated with scale up challenges due to the limited volume offered by these bioreactors for the production of biopharmaceuticals. The afore-mentioned restraints are likely to pose a limitation on the growth of single use bioreactor market size.

Growth Factors

Despite the challenges, several growth factors continue to drive the single use bioreactor market forward. One notable factor is the opportunity associated with developing nations. Various emerging nations such as Asia-Pacific and Latin America, present huge market growth potential for single use bioreactor manufacturers. Along with this, various technological advancements have also taken place in the past few years, contributing to the growth of single use bioreactors market. Given the advantages and growing adoption of these products, more industry players are anticipated to expand their existing portfolio to offer technologically advanced single use bioreactors.

Single use Bioreactors Market Segments

Based on the type of bioreactor, the market is segmented into Stirred Tank, Wave-Induced, and Other Bioreactors.

  • The stirred tank bioreactors segment led the single use bioreactors market, capturing the largest revenue share of close to 80.0% in 2023.
  • The other bioreactors segment is anticipated to show the highest market growth potential during the forecast period of around 19% annually.

Based on the scale of operation, the market is segmented into Lab, Clinical and Commercial.

  • The preclinical scale segment led the single use bioreactors market, capturing the largest revenue share of more than 70.0% in 2023.
  • The commercial scale segment is anticipated to show the highest market growth potential during the forecast period of around 19.0% annually.

Based on the type of cell culture, the market is segmented into Mammalian, Insect, Microbial, Viral, Plant, Bacterial and Others.

  • The mammalian segment led the single use bioreactors market, capturing the largest revenue share of around 50.0% in 2023.
  • The others segment is anticipated to show the highest growth potential by growing at a CAGR of over 16.5% during the forecast period.

Based on the end users, the market is segmented into Biopharmaceutical / Pharmaceutical Industries and Academic / Research Institutes.

  • The biopharmaceutical / pharmaceutical industries segment led the single use bioreactors market, capturing the largest revenue share of more than 65.0% in 2023.
  • The academic / research institutes segment is anticipated to show the highest growth potential by growing at a CAGR of over 16% during the forecast period.

Based on the application areas, the market is segmented into Cancer Research, Stem Cell Research, Tissue Engineering / Regenerative Medicine, Drug Discovery / Toxicity Testing and Others.

  • The cancer research segment led the single use bioreactors market, capturing the largest revenue share of around 40.0% in 2023.
  • The stem cell research, tissue engineering / regenerative medicine, drug discovery / toxicity testing segments are anticipated to show the highest growth potential by growing at a CAGR of over 15% during the forecast period.

Based on the Regional Insights, the market is segmented into North America, Europe, Asia-Pacific, Middle East and North Africa and Latin America.

  • North America dominated the single use bioreactors market and accounted for the largest revenue share of close to 40.0% in 2023.
  • In Asia-Pacific, the single use bioreactors market is anticipated to demonstrate lucrative growth during the forecast period.

Key Companies Profiled

The single use bioreactors market report also includes detailed profiles of key players (listed below) that offer single use bioreactors:

  • Applikon Biotechnology
  • Biolinx Labsystems
  • Celartia
  • Cell Culture Company 
  • Cellexus
  • Cercell
  • CESCO Bioengineering
  • Cytiva
  • Eppendorf
  • Merck Millipore
  • Pall Corporation
  • PBS Biotech
  • PerfuseCell
  • ProlifeCell
  • Sartorius Stedim Biotech
  • Solaris Biotech
  • Synthecon 
  • Thermo Fisher Scientific

You Can Download Free Sample PDF Copy of This Report At:
https://www.rootsanalysis.com/reports/single-use-bioreactors-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details

Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com
Blog: https://www.rootsanalysis.com/blog/single-use-bioreactors/

MEDIA CITATIONS

  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry